As the potential of GLP-1 agonists for addiction gains traction, big pharma is also starting to take notice, namely the two ...

Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.

Me, once valued at $6 billion, is now a penny stock. Layoffs, data breaches, and resignations led to its downfall. How did it ...

Take a deeper look at Catalonia’s biotech sector and overall life sciences hub, with Barcelona at the center of its success.

The companies Eikon Therapeutics, Sionna Therapeutics, and Abcuro bagged the biggest biotech funding rounds overall in ...

Discover 7 biotech companies in Taiwan, a rising regional player in precision medicine, immunotherapy, and drug development!

As we observe Rare Disease Day today, let us take a look at seven drugs poised to be approved to address rare diseases in ...

Find out what led biotech to a situation where women are underrepresented in clinical trials and how the industry is ...

Swiss pharma giant Novartis came out on top last month in the mergers and acquisitions (M&As) space with its buyout of Massachusetts-based Anthos Therapeutics. The deal is worth up to $2.15 billion in ...